Related Experiment Videos
Immune response to aflatoxin B1-histone H1 complex
1Cancer Research Laboratories, Department of Biochemistry, College of Medicine, University of Ibadan, Ibadan, Nigeria.
African Journal of Medicine and Medical Sciences
|May 31, 2001
Summary
Researchers developed specific antibodies against aflatoxin B1 by using aflatoxin B1-histone conjugates. These antibodies reduced mortality and liver toxicity in rats challenged with aflatoxin B1, suggesting potential for immunoprophylaxis against aflatoxicosis.
Area of Science:
- Immunology
- Toxicology
- Biochemistry
Background:
- Aflatoxin B1 is a toxic and carcinogenic mycotoxin posing significant health risks.
- Developing effective countermeasures against aflatoxin B1 toxicity is crucial for public health and agriculture.
Purpose of the Study:
- To generate specific antibodies against aflatoxin B1.
- To evaluate the protective efficacy of these antibodies against aflatoxin B1-induced toxicity in a rat model.
Main Methods:
- Antibodies were raised in rabbits using aflatoxin B1-histone H1 conjugates.
- Antibody specificity and binding affinity were characterized using Scatchard plot analysis.
- The protective effects were assessed in male Wistar rats challenged with aflatoxin B1 after immunization.
Main Results:
- Specific antibodies against aflatoxin B1 were successfully generated.
- Scatchard analysis indicated an average of 1.94 binding sites per antibody molecule with an association constant of 34.5 x 10(3) M-1.
- Immunized rats exhibited reduced mortality and acute liver toxicity upon aflatoxin B1 challenge.
Conclusions:
- The developed antibodies are specific for aflatoxin B1.
- Active immunization with aflatoxin B1-histone H1 conjugate confers protection against aflatoxin B1 toxicity.
- These antibodies hold promise for immunoprophylaxis against aflatoxicosis.